Figure 4From: Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis The hazard ratio (HR) of Ki-67 expression associated with the overall survival (OS) of DLBCL following and without following rituximab treatment. HR > 1 implied worse OS for the group with high Ki-67 expression.Back to article page